HY-134820-10mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
HY-134820-100mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
HY-134820-5mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
HY-134820-50mg
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1]
|
|
COVID-19-immunoregulation
|
|
HY-134820-1mL
|
MedChemexpress LLC
|
MLT-943 [CAS 1832576-04-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P99033-1mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|
HY-P99033-5mg
|
MedChemexpress LLC
|
Mosunetuzumab [CAS 1905409-39-3]
|
|
COVID-19-immunoregulation
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|